March 17, 2026

India and Russia are strengthening their pharmaceutical partnership.

Pharma

On March 16–17, 2026, an India-Russia pharmaceutical industry meeting is being held in Moscow. The event is organized by the Pharmaceutical Export Promotion Council of India (PHARMEXCIL), the Ministry of Commerce and Industry of the Government of India, and the Embassy of India in the Russian Federation.

The key objective of the meeting is to strengthen trade ties and elevate bilateral cooperation in the pharmaceutical sector to a new level. Delegates from more than 60 leading Indian pharmaceutical companies are participating in the event. For Russian partners, this presents a unique opportunity for direct negotiations with decision-makers and for securing mutually beneficial contracts with reliable manufacturers from India.

"Moscow views the pharmaceutical industry as one of the priority areas for international technological cooperation. The city has developed a robust scientific and industrial base, including pharmaceutical manufacturing facilities, research centers, and innovation hubs. This potential creates favorable conditions for localizing production, advancing joint research initiatives, and implementing cutting-edge medical technologies," emphasized Vyacheslav Manuylov, Deputy Head of the Department of Foreign Economic and International Relations of Moscow, in his address.

The Business Council for Cooperation with India, established under the Chamber of Commerce and Industry of the Russian Federation, plays a significant role in fostering such collaboration. Its activities are supported by the Government of Moscow and the Department of Foreign Economic and International Relations of Moscow. The Council has become an effective platform for systematic dialogue between Moscow-based and Indian companies, industry associations, and government bodies. Its work focuses on expanding business contacts, developing investment projects, and advancing industrial cooperation.

The Business Council actively promotes collaboration in the pharmaceutical sector. Representatives of Moscow-based enterprises and Indian companies participate in specialized industry forums, conferences, and business meetings, where they discuss the adoption of new technologies, the development of biopharmaceutical production, and joint scientific research. Within the framework of these events, Russian companies reaffirm their interest in expanding engagement with Indian partners in the development of biotechnological products and high-tech pharmaceuticals.

 

Source: Moscow Center for International Cooperation

Latest posts by email:
To subscribe to the newsletter, first Come in Either Register

Other news

Pharma

In today’s world, effective resource management is becoming an increasingly crucial aspect of successful business operations. This is especially true for industries where equipment plays a key role—such as pharmaceuticals, cosmetology, and the food industry.

02.10.2025
Pharma

At North America's largest packaging show PACK EXPO International 2026 (October 18-21, Chicago), Marchesini Group presented world premieres: a robotic high-speed line for monomaterial blisters and the new NPS robotic picking station with AI vision.

27.10.2026
Pharma

A new granulation line has been launched at the ALIUM pharmaceutical site (Binnopharm Group) in Obolensk, Moscow region. The equipment is designed for loads of up to 150 kg per cycle and significantly raised the plant's productivity, which is already heading toward 70 million packs of medicines a year.

19.10.2026
Pharma

A new administrative and production-warehouse complex of the pharmaceutical enterprise Farmstandart-UfaVITA has been commissioned in the center of Ufa. Investment exceeded 10 billion rubles, and new production lines are designed to produce 75 million medicine packages per year.

06.10.2026
Pharma

A Russian drugmaker, with the support of integrator IST-PAK, deployed an Italian SIEMPHARMA SRL counting-filling line for packaging tablets and capsules into plastic jars. The project was delivered despite a constrained shop floor and a fixed budget.

02.10.2026
Pharma

Farmasyntez Group commissioned a new pharmaceutical enterprise in Ussuriysk (Primorsky Krai). The plant with a design capacity of 12 million medicine packages a year was implemented under the import substitution program Pharma-2030; 90% of manufactured items are on the VED list.

01.10.2026
Pharma

Argumentum Pharma is completing the equipping of its new pharmaceutical plant in Moscow region's Dubna SEZ: high-tech automated filling and packaging lines have already been installed. Total investment in the project is estimated at 2.5 billion rubles, with commissioning planned before the end of 2026.

29.09.2026
Pharma

The Russian pharmaceutical manufacturer PFK "Renewal", operating under the Renewal brand, has commissioned a new production facility for the production of vital and essential medicines (VED) in the Novosibirsk region. The area of the complex exceeds 18.1 thousand square meters, and the design capacity reaches 100 million packages of finished products annually.

23.09.2026
Pharma

"VERTEX" is completing the commissioning of a blister-cardboard line with double-sided aluminum packaging, unique for its capacities. The new machine will become the tenth blister line of the enterprise and will allow to produce about 260 thousand packages by the end of 2026.

21.09.2026
Pharma

""""On Moscow Industry Day, Sergei Sobyanin opened a new production complex "Generium-Next" (GC "Farmstandart") at the Alabushevo site. The company will produce genetically engineered drugs for orphan and socially significant diseases for 8.5 billion rubles.

18.09.2026
Pharma

""PSK Pharma" company has completed a major project to modernize the production site of capsules with powder for inhalation at its own enterprise in the "Dubna" special economic zone. Investments exceeded 1 billion rubles, which made it possible to double the capacity of the line — from 80 to 160 thousand capsules per hour — and purchase new analytical and tablet equipment.

17.09.2026
Pharma

PJSC "Biosynthesis", one of the largest pharmaceutical enterprises in the Penza region, is preparing to launch a reconstructed production site for tablet dosage forms. The volume of investments in the project is 350 million rubles, and the implementation will increase the production of drugs, including those included in the list of VED.

16.09.2026